ELI LILLY & Co (LLY) operating KPIs

LLYNYSEPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value

$1417.54+43.84 (+3.19%)

Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%

Eli Lilly research and development ($M) ($M)

Quarterly figures from Eli Lilly's filings and investor materials

Quarterly Annual

Latest, Q2 2026

3,819

Period ended Jun 30, 2026

Change on a year earlier

+14.5%

3,336 in Q2 2025

History

69 quarters

Since Q2 2008

Sources

Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

Period	Ended	Research and development ($M) ($M)	Year on year	Source
Q2 2026	Jun 30, 2026	3,819	+14.5%	Form 10-Q (filed 2026-08-05) ↗
Q1 2026	Mar 31, 2026	3,510	+28.4%	Form 10-Q (filed 2026-04-30) ↗
Q4 2025	Dec 31, 2025	3,802	+25.8%	Form 10-K (filed 2026-02-12) ↗
Q3 2025	Sep 30, 2025	3,466	+26.8%	Form 10-Q (filed 2025-10-30) ↗
Q2 2025	Jun 30, 2025	3,336	+23.0%	Form 10-Q (filed 2026-08-05) ↗
Q1 2025	Mar 31, 2025	2,734	+8.4%	Form 10-Q (filed 2026-04-30) ↗
Q4 2024	Dec 31, 2024	3,023	+18.0%	Form 10-K (filed 2026-02-12) ↗
Q3 2024	Sep 30, 2024	2,734	+13.5%	Form 10-Q (filed 2024-10-30) ↗
Q2 2024	Jun 30, 2024	2,711	+15.1%	Form 10-Q (filed 2024-08-08) ↗
Q1 2024	Mar 31, 2024	2,523	+27.1%	Form 10-Q (filed 2024-04-30) ↗
Q4 2023	Dec 31, 2023	2,562	+28.4%	Form 10-K (filed 2026-02-12) ↗
Q3 2023	Sep 30, 2023	2,409	+33.6%	Form 10-Q (filed 2023-11-02) ↗
Q2 2023	Jun 30, 2023	2,357	+32.2%	Form 10-Q (filed 2023-08-08) ↗
Q1 2023	Mar 31, 2023	1,985	+23.3%	Form 10-Q (filed 2023-04-27) ↗
Q4 2022	Dec 31, 2022	1,996	+5.1%	Form 10-K (filed 2023-02-22) ↗
Q3 2022	Sep 30, 2022	1,803	+5.7%	Form 10-Q (filed 2022-11-01) ↗
Q2 2022	Jun 30, 2022	1,782	+7.7%	Form 10-Q (filed 2022-08-04) ↗
Q1 2022	Mar 31, 2022	1,610	-3.7%	Form 10-Q (filed 2022-04-29) ↗
Q4 2021	Dec 31, 2021	1,898	+9.8%	Form 10-K (filed 2023-02-22) ↗
Q3 2021	Sep 30, 2021	1,705	+16.4%	Form 10-Q (filed 2022-11-01) ↗
Q2 2021	Jun 30, 2021	1,655	+19.0%	Form 10-Q (filed 2022-08-04) ↗
Q1 2021	Mar 31, 2021	1,672	+20.1%	Form 10-Q (filed 2022-04-29) ↗
Q4 2020	Dec 31, 2020	1,729	+9.3%	Form 10-K (filed 2023-02-22) ↗
Q3 2020	Sep 30, 2020	1,465	+6.1%	Form 10-Q (filed 2020-10-28) ↗
Q2 2020	Jun 30, 2020	1,390	-0.9%	Form 10-Q (filed 2020-07-31) ↗
Q1 2020	Mar 31, 2020	1,392	+13.1%	Form 10-Q (filed 2020-05-01) ↗
Q4 2019	Dec 31, 2019	1,581	+13.6%	Form 10-K (filed 2020-02-19) ↗
Q3 2019	Sep 30, 2019	1,381	+7.8%	Form 10-Q (filed 2019-10-25) ↗
Q2 2019	Jun 30, 2019	1,402	+10.3%	Form 10-Q (filed 2019-08-02) ↗
Q1 2019	Mar 31, 2019	1,231	+11.1%	Form 10-Q (filed 2019-05-02) ↗
Q4 2018	Dec 31, 2018	1,392	+13.5%	Form 10-K (filed 2020-02-19) ↗
Q3 2018	Sep 30, 2018	1,281	-4.4%	Form 10-Q (filed 2019-10-25) ↗
Q2 2018	Jun 30, 2018	1,271	-0.1%	Form 10-Q (filed 2019-08-02) ↗
Q1 2018	Mar 31, 2018	1,108	-12.0%	Form 10-Q (filed 2019-05-02) ↗
Q4 2017	Dec 31, 2017	1,226	-19.2%	Form 10-K (filed 2020-02-19) ↗
Q3 2017	Sep 30, 2017	1,340	+8.4%	Form 10-Q (filed 2018-11-06) ↗
Q2 2017	Jun 30, 2017	1,272	-4.8%	Form 10-Q (filed 2018-07-25) ↗
Q1 2017	Mar 31, 2017	1,258	+3.1%	Form 10-Q (filed 2018-04-27) ↗
Q4 2016	Dec 31, 2016	1,517	+5.0%	Form 10-K (filed 2019-02-19) ↗
Q3 2016	Sep 30, 2016	1,236	+8.1%	Form 10-Q (filed 2016-10-28) ↗
Q2 2016	Jun 30, 2016	1,336	+14.2%	Form 10-Q (filed 2016-07-28) ↗
Q1 2016	Mar 31, 2016	1,221	+17.5%	Form 10-Q (filed 2016-04-29) ↗
Q4 2015	Dec 31, 2015	1,444	+21.8%	Form 10-K (filed 2016-02-19) ↗
Q3 2015	Sep 30, 2015	1,143	-8.0%	Form 10-Q (filed 2015-10-30) ↗
Q2 2015	Jun 30, 2015	1,170	-2.2%	Form 10-Q (filed 2015-07-30) ↗
Q1 2015	Mar 31, 2015	1,039	-6.3%	Form 10-Q (filed 2015-04-30) ↗
Q4 2014	Dec 31, 2014	1,186	–	Form 10-K (filed 2015-02-19) ↗
Q3 2014	Sep 30, 2014	1,243	–	Form 10-Q (filed 2014-10-29) ↗
Q2 2014	Jun 30, 2014	1,195	-10.1%	Form 10-Q (filed 2014-07-28) ↗
Q1 2014	Mar 31, 2014	1,109	-17.7%	Form 10-Q (filed 2014-04-28) ↗
Q2 2013	Jun 30, 2013	1,330	+0.7%	Form 10-Q (filed 2013-07-26) ↗
Q1 2013	Mar 31, 2013	1,348	+17.1%	Form 10-Q (filed 2013-04-26) ↗
Q4 2012	Dec 31, 2012	1,463	–	Form 10-K (filed 2013-02-21) ↗
Q3 2012	Sep 30, 2012	1,343	-47.2%	Form 10-Q (filed 2012-10-26) ↗
Q2 2012	Jun 30, 2012	1,321	–	Form 10-Q (filed 2012-07-27) ↗
Q1 2012	Mar 31, 2012	1,152	+2.4%	Form 10-Q (filed 2012-04-30) ↗
Q2 2011	Sep 30, 2011	2,542	+108.4%	Form 10-Q (filed 2011-10-28) ↗
Q1 2011	Mar 31, 2011	1,124	+8.2%	Form 10-Q (filed 2011-04-29) ↗
Q4 2010	Dec 31, 2010	1,438	+18.2%	Form 10-K (filed 2011-02-22) ↗
Q3 2010	Sep 30, 2010	1,220	+8.7%	Form 10-Q (filed 2010-10-29) ↗
Q2 2010	Jun 30, 2010	1,187	+14.1%	Form 10-Q/A (filed 2010-08-02) ↗
Q1 2010	Mar 31, 2010	1,039	+9.7%	Form 10-Q (filed 2010-04-30) ↗
Q4 2009	Dec 31, 2009	1,217	+14.9%	Form 10-K (filed 2010-02-22) ↗
Q3 2009	Sep 30, 2009	1,122	+17.7%	Form 10-Q (filed 2009-10-30) ↗
Q2 2009	Jun 30, 2009	1,040	+9.3%	Form 10-Q (filed 2009-07-31) ↗
Q1 2009	Mar 31, 2009	947	–	Form 10-Q (filed 2010-04-30) ↗
Q4 2008	Dec 31, 2008	1,059	–	Form 10-K (filed 2010-02-22) ↗
Q3 2008	Sep 30, 2008	953	–	Form 10-Q (filed 2009-10-30) ↗
Q2 2008	Jun 30, 2008	952	–	Form 10-Q (filed 2009-07-31) ↗

Cite this data

StockData. (2026). Eli Lilly Research and development ($M) ($M), quarterly Q2 2008–Q2 2026 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/fin_rd

See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.